Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lixte Biotechnology Holdings (LIXT) Cash from Financing Activities (2016)

Lixte Biotechnology Holdings' Cash from Financing Activities history spans 6 years, with the latest figure at $581332.0 for Q2 2016.

  • For Q2 2016, Cash from Financing Activities rose 84.55% year-over-year to $581332.0; the TTM value through Dec 2016 reached $1.7 million, changed N/A, while the annual FY2025 figure was $10.3 million, N/A changed from the prior year.
  • Cash from Financing Activities reached $581332.0 in Q2 2016 per LIXT's latest filing, down from $1.2 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $7.5 million in Q2 2012 to a low of $33333.0 in Q1 2012.
  • Average Cash from Financing Activities over 5 years is $4.7 million, with a median of $7.5 million recorded in 2012.
  • Peak YoY movement for Cash from Financing Activities: plummeted 76.98% in 2015, then soared 84.55% in 2016.
  • A 5-year view of Cash from Financing Activities shows it stood at $7.5 million in 2012, then changed by 0.0% to $7.5 million in 2013, then changed by 0.0% to $7.5 million in 2014, then crashed by 95.83% to $315000.0 in 2015, then surged by 84.55% to $581332.0 in 2016.
  • Per Business Quant, the three most recent readings for LIXT's Cash from Financing Activities are $581332.0 (Q2 2016), $1.2 million (Q1 2016), and $315000.0 (Q2 2015).